Hold the Line

Exposing Military Corruption during COVID-19

 1. This presentation will show irrefutable evidence that the DoD, in concert with the FDA and
CDC, sought to create the conditions to mandate a vaccination campaign for DoD that was
neither necessary nor legal.
2. Within this document there will be questions asked that, when answered honestly, should lead to the BLUF
conclusions aforementioned, but holding those accountable for the answers is beyond the scope of the
authors.
3. Utilize the mechanisms built into this document to go back and forth between key points or articles.
Timeline of key events

Fully Licensed Title 21 21 USC 207.37c Ref. Products Approved RAs Conclusions

5 mos. Post- The Labels Mil Mandates Military CFR Defense Med
Other approval
EUA v Approved Terry Adirim Military Coercion
Navigation Comirnaty Accommodations
FOIA Exemption Outside her SECDEF Conflict
Items: unavailable
Discrimination
authority SECDEF Conflict
Start/ End Dates DHCP Letter
2
 On August 24, 2021
THE
Secretary of Defense
Lloyd Austin signed a
memo for the mandatory
ORDER
vaccination against Covid
19 for all Service
Members Ask yourself:
 Do you know if the military is
receiving fully approved product,
This memo explicitly or are other products being used
states that the only as substitutes?
vaccines for use will,
“Receive full licensure
from the Food and Drug
Back to
Administration (FDA), Timeline
in accordance with
FDA-approved labeling
and guidance.”

1. https://media.defense.gov/2021/Aug/25/2002838826/-1/-1/0/MEMORANDUM-FOR-MANDATORY-CORONAVIRUS-DISEASE-2019-
VACCINATION-OF-DEPARTMENT-OF-DEFENSE-SERVICE-MEMBERS.PDF
FULLY What is required to be a “fully licensed” product ?

LICENSED Per the Public Health Service Act,

Ask yourself:
Licensure of a Biologic is a multifaceted process:  Do you know what it means if you have a
BLA approval letter?
1. Approval of a Biologics Licensing Application  Is the manufacturer using the same
facilities, and the same equipment, and the
2. Limited to the manufacturing process and locations that same process to create the drug as is
specified in the BLA approval, or has it been
are approved in the Application submitted to the FDA changed since the letter was written?
 Do you know the impact of label laws on
3. Labeling Requirements that are approved by the FDA this process?

Each Label must possess:

 Do you know that the vial you receive must
1. The Proprietary Name of the Product say COMIRNATY to be a fully approved
product?
2. The License Number  Did you receive a vial that said “Pfizer-
Biontech COVID-19 vaccine?”
 Do you know what a “BLA approved” lot is?
3. The Name and Address of the Manufacturer
 Did you receive an approved lot?
 Is/ Was the product you received within its
4. The Expiration Date expiration date?

Back to
1. https://www.law.cornell.edu/uscode/text/42/262 Timeline
THE PRODUCT
IS NOT
THERE.. See date, this
is 5 months
post
approval

After 5 months
of operating, Ask yourself:
they don’t have  If this one base
any approved is operating
product at all without
approved
yet?
product, where
else is this
situation
happening?
 Who else is
receiving
substitutes?

Back to
Timeline
 ..AND WON’T
BE

USPI_Comirnaty_COVID 19 Vaccine_mRNA_suspension for injection.PDF

Ask yourself:
 If Pfizer hasn’t produced any approved product yet, when did they plan on producing it, if ever?
 Was the intent of saying it is “interchangeable” simply to give cover for Pfizer’s potential losses from mass
manufacture of EUA product? Back to
Timeline
 Codes ending in
‘2’ and ‘3’
Corresponding
to BLA Approval

Note the Marketing ‘Start’

WHAT and ‘End’ dates

IS Ask yourself:

THIS?  Why was the Marketing ‘End’ date made to be the same as the ‘Start’ date?

1. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=618348
Back to
Timeline
 TITLE
Title 21, Ch. 1, Subchapter F,
Part 601.5 goes into the
21
revocation of a biologics
license if the manufacturer
states its intent to discontinue
manufacture of the product
they applied to have licensed

Ask yourself:
 If Pfizer submitted an Expiration Date with
their application, should FDA have revoked
their Biologics License Application?
 Is it legal to never intend to produce a drug
with the FDA’s knowledge of this intent?
 Pfizer has continued to manufacture EUA
labeled lots after the approval of
Comirnaty. Why?

Back to
Timeline
1. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-601
 1

THE
LABELS
1. Pfizer’s full
EUA Prescribing
Information provides
compliant NDC label codes.

3 2. DailyMed search results for

Comirnaty prior to 16 DEC 2021
showed NDC codes matching
authorized product.

3. Pfizer’s labels clearly indicate that it is for

Emergency Use Authorization (EUA).

4. Emergency Use Authorization NDC code.

2
3

Ask yourself:
 Why would Pfizer move forward in labeling their product with compliant NDC codes, when:
 1. They had no intention of creating COMIRNATY or any other compliant lots until the EUA product was used up?
 2. It goes against label laws to misbrand product?
Back to
1. https://labeling.pfizer.com/ShowLabeling.aspx?id=14471&format=pdf Timeline
2. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908ecbe7-2f1b-42dd-94bf-f917ec3c5af8
 Take note of the NDC
code on both labels

COMIRNATY (FDA Approved) Pfizer-BioNTech COVID-19 Vaccine (EUA)

EUA v Ask yourself:

 Why would Pfizer misbrand an EUA product?

APPROVED  Why can you not find any licensed product at pharmacies and bases in the United States?
 Why haven’t the EUA products been recalled/ destroyed by now if we have a licensed product?

PACKAGING 1. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=595377
Back to
Timeline
 FOIA
EXEMPTION

Ask yourself:
 Why would the cap need a FOIA exemption
if anyone who handles the vials after
1. The left image here shows that one vial of Pfizer-Biontech vaccine is 1.8 mL
approval can see them?
2. The right image shows that COMIRNATY should be shipped as a 2 mL vial, with  What else was redacted, and what is the
a specific covering material. The rest of the description is classified (b) (4). This justification of allowing the redaction?
document, the November 8 Summary Basis for Regulatory Action –  Why would Pfizer NOT want to share how
COMIRNATY, has numerous sections where this particular classification is cited it’s made after a reasonable period of time
for the redactions made.
after they made their money back?
3. A (b) (4) classification is a Freedom of Information Act exemption code that  Why go to these lengths to conceal as
“permits agencies, as a matter of discretion, to withhold trade secrets and much information as possible about their
commercial or financial information obtained from a person which is privileged or vaccine if it were such a miracle of
confidential.” science?

1. https://www.fda.gov/media/151733/download
2. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908ecbe7-2f1b-42dd-94bf-f917ec3c5af8
3. https://www.acus.gov/recommendation/exemption-b4-freedom-information-
Back to
act#:~:text=Exemption%20(b)(4)%20of%20FOIA%20permits%20agencies%2C%20as,which%20is%20privileged%20or%20confidential Timeline
 1. A Dear Health Care Professional (DHCP) letter is supposed to
provide any updated information on a drug to healthcare
professionals who administer the drug to patients.
2. The DHCP letter came with information on “BLA approved lot #’s” that
were supposed to be compliant. The first seven lots in the “additional lot
details” were manufactured prior to 23 AUG 2021, the last two were
manufactured after the approval but retain EUA labels.
3. These lot #’s are all considered to be “BLA-compliant” minus the labeling. These
cannot be deemed approved, or compliant, if they were manufactured before the
approval date, and are marked with the EUA labels.

Ask yourself:
 How many doses does this represent if lots have been arbitrarily given these
lot #’s and passed off as BLA-compliant?
 Is there no properly labeled “Comirnaty” vaccine in the United States? Lot # NDC Codes:
(59267-1000-02) Mfd before approval
(59267-1000-03)

Mfd after approval

Back to
Timeline NDC11 Unit of Sale: This NDC NDC11 Unit of Use:
Manufacturer goes in NYSIIS Inventory This NDC will be on the vial Lot Number Manufacture Date Expiration Date Date Last Updated

DHCP Pfizer Inc.

Pfizer Inc.
Pfizer Inc.
59267-1000-02
59267-1000-03
59267-1000-02
59267-1000-01
59267-1000-01
59267-1000-01
FE3592
FD7220
FF2588
6/30/2021
6/23/2021
7/4/2021
2/28/2022
11/30/2021
3/31/2022
8/27/2021
8/6/2021
8/27/2021

LETTER & Pfizer Inc.

Pfizer Inc.
Pfizer Inc.
59267-1000-02
59267-1000-02
59267-1000-02
59267-1000-01
59267-1000-01
59267-1000-01
FD7220
FF2590
FF8841
6/23/2021
7/6/2021
7/23/2021
2/28/2022
3/31/2022
3/31/2022
8/27/2021
8/27/2021
8/27/2021
Pfizer Inc. 59267-1000-02 59267-1000-01 FF2587 7/2/2021 3/31/2022 8/27/2021

LOT #’S Pfizer Inc. 59267-1000-02 59267-1000-01 FF2593 7/6/2021 3/31/2022 8/27/2021
Title 21, Chapter 1, Subchapter C, §207.37c - What restrictions pertain to the
use of the NDC?

(a) A product may be deemed to be misbranded if an NDC is used:

(1) To represent a different drug than the drug for which the NDC has been
assigned, as described in § 207.33;

(2) To denote or imply FDA approval of a drug; or

(3) On products that are not subject to parts 207, 607 of this chapter, or 1271 of
this chapter, such as dietary supplements and medical devices.

(b) If marketing is resumed for a discontinued drug, and no changes have been
made to the drug that would require a new NDC under § 207.35, the drug must
have the same NDC that was assigned to it as described in § 207.33, before
marketing was discontinued.
Ask yourself:
 Are the FDA and DoD Perpetrating a fraud by implying that these EUA labeled vaccines are the licensed
product?
 Why would the DoD, an organization that needs to conduct its own Mission Analysis with its own personnel,
simply take FDAs messaging at face value, along with all of the results of studies conducted by Pfizer,
without demanding copies of the data to verify its own analysis and tailor the proliferation of the vaccine
according to its own mission?
21 USC
1. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-207/subpart-C/section-207.37
Back to
Timeline SEC 207.37c
 How can the Department of Defense carry out a mandatory vaccination
program that only has products marked for “Emergency Use”?

DoD is relying on 2 letters to carry out the mandate:

1. The “Dear Healthcare Professional” (DHCP) letter denoting “BLA Compliant”
lots.

2. A memo from Terry Adirim, ASD(HA), directing DoD providers to use the EUA
doses as if they were licensed product.
Ask yourself:
 Why was Pfizer allowed to determine
what lots are “BLA compliant?”
 Where are the FDA inspectors who are
supposed to ensure compliance with
the BLA manufacturing process?
 Why is DoD no longer enforcing the
option to refuse when all product is
EUA?

BASIS OF
MANDATES
Back to
Timeline
THE MEMO 1. In a guidance memo presented by Terry Adirim on
September 14, 2021, there is a conflict with the
BY TERRY guarantees presented within Secretary Austin’s memo

2. Terry Adirim does not have the legal authority to advise any health

ADIRIM administrator to present EUA labeled vials as licensed, or to create

policy mandating EUA vaccines to service members. This authority is
left solely to the discretion of the President.

3. As of JAN 2022, the President has not signed any waivers to informed consent.

4. There is a claim made in this memo that these products can be used “interchangeably.”
Interchangeable is defined by the FDA as:

“An interchangeable product is a biosimilar product that meets additional requirements

outlined by the Biologics Price Competition and Innovation Act. As part of fulfilling
these additional requirements, information is needed to show that an interchangeable
product is expected to produce the same clinical result as the reference product in any
given patient.”
5. At present neither the Pfizer-Biontech vaccine nor Comirnaty are listed as
biosimilar in the FDA’s “Purple Book,” a requirement to be considered
“interchangeable.”

Ask yourself:
 Who gave direction to Terry Adirim to put out a memo that
directed usage of the Pfizer-Biontech COVID-19 vaccine
as “interchangeable” with Comirnaty?
 Why would the Assistant Secretary of Defense for Health
Affairs presume to direct health care providers to
administer certain products?
Back to
Timeline
 Terry Adirim has acted outside the scope of her authority

According to 10 USC, §1107a. Emergency use products

(a) Waiver by the President.-(1) In the case of the administration of a product authorized for emergency use under section 564 of
the Federal Food, Drug, and Cosmetic Act to members of the armed forces, the condition described in section 564(e)(1)(A)(ii)(III) of
such Act and required under paragraph (1)(A) or (2)(A) of such section 564(e), designed to ensure that individuals are informed
of an option to accept or refuse administration of a product, may be waived only by the President only if the President
determines, in writing, that complying with such requirement is not in the interests of national security.

By issuing a directive
Directive that repeats claims made by FDA that the Pfizer product was “interchangeable,” and directing military healthcare
professionals to use EUA products as if they were approved, she has contributed to a violation of the tenets of 10 USC section 1107a by
removing the option to accept or refuse the administration of a product that is under the provisions of an Emergency Use Authorization.

Judge Allen Winsor, in a denial

denial for preliminary injunction order in Doe v Austin, stated: “Pfizer developed a COVID-19 vaccine, for which the FDA
issued an Emergency Use Authorization (“EUA”). This allowed Pfizer to distribute the vaccine starting in December 2020. ECF No. 1-6 at 2-3. An
EUA is not a full FDA license.”

As the acting Assistant Secretary of Defense for Health Affairs, Terry Adirim has a wide range of personnel, from medical to legal, at her disposal to ascertain the
legality of using the FDA’s approval at face value. In fact, she has a duty to determine that an order is lawful or not, regardless if it came from the Secretary of
Defense.

Ask yourself:
 Was Terry Adirim a witting accomplice in pursuing this mandate for all servicemembers?
 Or, was Terry Adirim acting on her own to ensure that the orders of the SECDEF were reinforced by a memo from
the Office of the ASD(HA)?
 If the SECDEF and Terry Adirim were NOT aware that Comirnaty was not going to be made available, wouldn’t the
option to continue to refuse be made known to servicemembers after learning that it would not be made available

SCOPE OF at any time in the near future?

AUTHORITY
Back to
Timeline
Reference Product
REFERENCE
A reference product is the single biological product, already approved by FDA, against which a
proposed biosimilar product is compared. A reference product is approved based on, among PRODUCTS
other things, a full complement of safety and effectiveness data. A proposed biosimilar product is
compared to and evaluated against a reference product to ensure that the product is highly
similar and has no clinically meaningful differences.
A product cannot be legally deemed interchangeable when there is no reference product.

Ask yourself:
Biologic Interchangeable Products are called “Biosimilars”  Is it intentionally fraudulent to make the claim that a
product is interchangeable when it is not?
This means both products must be FDA approved.  Were those responsible for the messaging that it is
One cannot retain authorization while the other has approval. “interchangeable” reasonably assumed to know this
definition when disseminating that messaging?
Each biosimilar and each reference product are required to go through  Can Terry Adirim speak to this misrepresentation of the
the entire approval process outlined in the Public Health Service Act law?
Section 351(k) to be deemed interchangeable.  Is there any accountability for those denying service
members their right to informed consent?

This is separate from Emergency Use Authorization, and they both have
different statutory regulations.

Back to
Timeline
 US and Military Case Fatality Rates (CFR) Compared
MILITARY 1. The military’s fully vaccinated rate rose 283% faster than the US rate since 24 AUG 21.
CFR 2. While the US CFR has dropped by 43% from it’s average since the military vaccine mandate, the
military CFR has increased by 54% from its average since the mandate. (fig 2)
3. Since the mandate, the military fully vaccinated rate rose 30% while the US rate only rose 10.6%. (fig 3)

Ask yourself:
 Why didn’t the military CFR drop as low or lower than the US CFR since AUG 21?
 Why did the military CFR increase 54% since the mandate while the US CFR decreased 43%?

Cases Fatality Rate US Cases Fatality Rate Military Fully Vaccinated Rate % Increase
0.0004
Since Military Vaccine Mandate
0.012
30
0.00035

0.01
0.0003 25

0.008 0.00025
20

0.0002
0.006 15
0.00015
0.004 10
0.0001

0.002 5
0.00005

0 0 0
CFR CFR Since 24 Aug 21
1 Since Pandemic Start Since 24 Aug 21 2 Since Pandemic Start Since 24 Aug 21 3 US Military

Back to
Timeline
Military Medical and Religious Accommodations
Service members do not lose their Constitutional freedoms just because they signed on the
dotted line to serve their country.

Medical waivers are granted based on:

 Contraindications
 Allergies or allergies to vaccine components
 Sensitivity
 “Undesirable reactions”
 Underlying health conditions (for example, based on immune competence, pharmacologic or radiation
therapy, pregnancy and/or previous adverse response to immunization).
 Evidence of immunity based on serologic tests, documented infection, or similar circumstances.

Medical doctors and PCMs used to have the freedom to grant medical waivers as they saw fit. However,
these physicians are now afraid to write medical exemptions because they could have their medical license
subjected to investigation or face disciplinary action for issuing exemptions, writing "too many" exemptions,
or exemptions that are deemed "inappropriate."
Religious accommodations have been in place, specified in regulations, since 1971, and
service members can request a religious accommodation for some or all vaccines
based on their belief.
Back to
Ask yourself: Timeline
 Why are providers afraid to write medical exemptions since covid?
 What kind of Command Climate fosters fear to do your duty as a medical
provider, and do right by the Soldier, Sailor, or Airmen who needs a medical
MILITARY
waiver to continue to serve honorably?
ACCOMMODATIONS
 “Legitimate Religious Objection”
“First, a religion addresses fundamental and ultimate questions having to do with deep and imponderable
matters. Second, a religion is comprehensive in nature; it consists of a belief system as opposed to an
isolated teaching. Third, a religion often can be recognized by the presence of certain formal and external
signs.” (Africa v. Pennsylvania, 662 F.2d 1025, 1031 (3d Cir. 1981), the Third Circuit Court of Appeals)
A sincere religious believer doesn’t forfeit his/her religious rights merely because s/he is not scrupulous in
his/her observance or had never openly demonstrated those beliefs in the past. Furthermore, a person can
become religious at any point in their life, even if they previously did not have religious objections.

Whether a belief is “sincerely held” is generally an issue of individual credibility. Evidence proving sincerely held
religious beliefs is difficult to obtain in most cases, and often can be overcome, as sincerely held religious beliefs
are not static and often change over time.
Religious Discrimination Based on Vaccination Refusal
Title VII makes it an unlawful employment practice for an employer to discharge or discriminate against an employee
Title VII
because of an individual’s religion. The term religion “includes all aspects of religious observance and practice, as
well as belief, unless an employer demonstrates that he is unable to reasonably accommodate an employee’s or
prospective employee’s religious observance or practice without undue hardship on the conduct of the employer’s
business.”
To establish a claim of religious discrimination under Title VII, the employee must show that (1)
Back to
Timeline
they held a sincere religious belief that conflicted with a job requirement; (2) they informed their
employer of the conflict; and (3) they were disciplined for failing to comply with the conflicting
requirement. Employers have a statutory obligation under Title VII to make reasonable
accommodations for the religious observances of employees, but are not required to incur
RELIGIOUS undue hardship.
 Ask yourself: What is the percentage of service members who were judged to be “insincere” in their
DISCRIMINATION beliefs when they applied for their accommodation? Answer
 “A way of life”
APPROVED Associate Justice Kathryn Mickle Werdegar, observed that a religious belief is something
other than “a philosophy or a way of life.” She further explained that “Religious beliefs need
RA’s not be acceptable, logical, consistent, or comprehensible to others in order to merit First
Amendment protection.”
Service members who have approved Some personnel who currently have approved RAs
RAs are able to: (prior to COVID):
• Conduct a move to both OCONUS and • 11B Infantryman
CONUS installations • 68W Field Medic
• Deploy to combat theaters • 11C Mortarman
• Rotate into non-combat theaters • 19K M1 Armor crewman
• Attend training • 13D Artilleryman
• Attend schools • 17E Electronic Warfare
• Go on TDY • 153D UH-60 pilot
Many, if not all, of these personnel have not had their standing accommodations recognized. Guidance
from the DoD has specifically stated that previously approved accommodations do not apply to covid,
and have had their careers threatened just the same as those who do not have accommodations
already in place. They face punishments and adverse actions that do not fall under the Uniform Code of
Military Justice, and so go either unnoticed or the leadership turns their eyes to the grievous injustice
happening to them. Back to
Ask yourself: Timeline
 If a Soldier can say they are an Atheist and still claim a religious belief, why are military leaders denying
those who claim established religions their own beliefs?
 Why are senior military Chaplains fighting so hard to deny military service members their rights, with
guidance that instructs them to rebut arguments about aborted fetal cells?
 Why is the institution of the DoD gathering and disseminating statements from religious leaders in support of
vaccination to deny service members their right to request accommodation?
 Date Obtained 2016 2017 2018 2019 2020 Avg Injuries Per Year 2016-2020 Jan to Oct 2021 Percentage Change vs Avg in 2021

Defense
1/10/2022 O03 SPONTANEOUS Abortion 1,431 1,518 1,493 1,578 1,477 1499.4 4,182 278.91%
1/10/2022 Acute Pericarditis Hospitalized 49 54 58 48 54 52.6 41 77.95%
1/10/2022 I30 Acute Pericarditis Amb 535 538 522 531 499 525 850 1.619047619
1/19/2022 I30 Acute Pericarditis Amb 454 401 410 419 363 363
1/10/2022 I40 Acute Myocarditis Hosp 17 17 18 33 14 19.8 15 75.76%
12/6/2021 I51.4 Myocarditis, Unspecified Amb 20 30 29 41 33 877

Medical 1/10/2022
1/19/2022

8/29/2021
1/10/2022
I40 Acute Myocarditis Amb
I40 Acute Myocarditis Amb
I40 I41 I 51 ACUTE MYOCARDITIS MYOCARDITIS IN DISEASES CLASSIFIED ELSEWHERE
COMPLICATIONS AND ILL DEFINED DESCRIPTIONS OF HEART DISEASE
A00 to Z99 All disease and injuries Hosp
84
59

43,786
92
62
116
62

Total 216 all five years

43,338 42,024 43,493

159
93
108
67

40,052
111.8
68.6
43.2

42538.6
263
118

1239
54,776
2.352415027
172.01%

2868.06%
128.77%

data
1/10/2022 AMS Hosp 54 41 42 36 27 40 25 62.50%
1/10/2022 AMS Amb 695 723 689 732 700 707.8 2,115 298.81%
1/10/2022 Anxiety Hosp 2,478 2,577 2,534 2,666 2,642 2579.4 6496 251.84%
1/10/2022 Anxiety Amb 37,011 36,667 36,145 37,762 37,870 37091 931,791 2512.18%
1/10/2022 appendicitis Hosp 648 654 690 795 717 700.8 1182 168.66%
1/10/2022 appendicitis Amb 1,977 1,930 2,298 2,633 2,593 2286.2 5,547 242.63%
1/10/2022 Bells Palsy Hosp 12 16 13 12 15 13.6 14 102.94%
1/10/2022 Bell's Palsy Amb 483 462 457 447 450 459.8 1338 291.00%
1/10/2022 Brain dead Hosp 1 0 0 0 0 0.2 1 500.00%
1/10/2022 Brain dead Amb 19 17 11 17 19 16.6 10 60.24%

Raw data from the Defense 1/10/2022

1/10/2022
1/10/2022
breast cancer Hosp
breast cancer Amb
cerebral Infarction Hosp
46
934
107
43
810
108
41
766
124
33
792
95
25
766
107
37.6
813.6
108.2
17
3963
86
45.21%
487.09%
79.48%

Medical Epidemiology 1/10/2022

8/29/2021
cerebral Infarction Amb
chest Pain Amb
887
153
848
142
858
142
888
192
887
184
873.6
162.6
3136 358.97%
0.00%

Database, accessible only by

1/10/2022 cognitive Hosp 6 5 4 5 3 4.6 1 21.74%
1/10/2022 cognitive Amb 484 430 403 459 421 439.4 1772 403.28%
1/10/2022 Cognitive malformations Hosp 270 236 211 236 197 230 180 78.26%

military medical providers. 1/10/2022

1/10/2022
Congenital malformations amb
demylinating Hosp
11,710
41
11,134
74
10,457
59
11,081
45
10,152
40
10906.8
51.8
16,988
34
155.76%
65.64%
1/10/2022 demylinating Amb 785 737 690 677 648 707.4 3145 444.59%
1/10/2022 diseases of liver hosp 77 75 82 92 100 85.2 100 117.37%
1/10/2022 disease of liver Amb 1,994 2,053 2,063 2,234 2,322 2133.2 6187 290.03%

Shows increases in all 1/10/2022

1/10/2022
DM! Hosp
DM1 Amb
63
1,319
57
1,167
70
1,072
53
1,036
67
960
62
1110.8
60
5269
96.77%
474.34%

categories of acute and non- 1/10/2022

1/10/2022
dysmenohrea Hosp
dysmenohrea Amb
29
3,104
35
3,403
32
3,481
30
3,943
22
3,900
29.6
3566.2
12
12,539
40.54%
351.61%
1/10/2022 dz of arteries Hosp 80 83 66 78 75 76.4 53 69.37%
specific disease and injury. 1/10/2022
8/29/2021
dz of arteries amb
E00 to E89 Endocrine nutritional and metabolic diseases
3,164
33,140
2,965
31,825
2,938
30,814
3,096
31,504
2,860
30,506
3004.6
31557.8
6069 201.99%
0.00%
1/10/2022 esophageal cancer hosp 6 2 8 3 0 3.8 2 52.63%
1/10/2022 esophageal cancer amb 29 36 35 20 26 29.2 209 715.75%
1/10/2022 extra pyramidal hosp 12 24 23 11 14 16.8 5 29.76%
1/10/2022 extra pyramidal amb 1,509 1,474 1,339 1,371 1,338 1406.2 3669 260.92%
1/10/2022 eye disorder hosp 13 18 14 24 14 16.6 10 60.24%
1/10/2022 eye disorder Amb 6,044 6,013 5,647 6,312 5,623 5927.8 11,892 200.61%
1/10/2022 female infertility hosp 11 7 7 3 2 6 1 16.67%
1/10/2022 female infertility Amb 2,261 2,262 2,242 2,333 2,260 2271.6 10,713 471.61%
1/10/2022 GBS Hosp 25 29 30 30 21 27 18 66.67%
1/10/2022 GBS Amb 66 79 71 85 65 73.2 403 550.55%
1/10/2022 HIV Amb 599 455 412 415 392 454.6 2,460 541.14%
1/10/2022 HSV Hosp Hosp 4 4 0 4 2 2.8 4 142.86%
1/10/2022 HSV Hosp Amb 1,734 1,779 1,724 1,786 1,678 1740.2 2350 135.04%
1/10/2022 Neoplasm Hosp 1,452 1,341 1,174 1,211 1,094 1254.4 922 73.50%
1/10/2022 Neoplasm Amb 41,557 39,139 37,751 38,887 36,044 38675.6 103,606 267.88%
1/10/2022 HTN Hosp 66 44 48 39 45 48.4 51 105.37%
Back to 1/10/2022 HTN Amb 2,308 2,323 2,363 2,392 2,415 2360.2 53,846 2281.42%
1/10/2022 infertilty male 2,187 2,287 2,037 2,151 1,990 2130.4 7551 354.44%
Timeline 1/10/2022 Inflammation NS Hosp 112 112 94 86 81 97 37 38.14%
1/10/2022 Inflammation NS Amb 664 669 560 555 457 581 998 171.77%
1/10/2022 Malasie & fatigue Hosp 34 36 32 25 28 31 31 100.00%
1/10/2022 Malasie & fatigue Amb 3,851 3,842 3,832 3,885 3,735 3829 26,416 689.89%

1. https://www.afhsc.mil/DMED
 Date Obtained 2016 2017 2018 2019 2020 Avg Injuries Per Year 2016-2020 Jan to Oct 2021 Percentage Change vs Avg in 2021
1/10/2022 Migraines Hosp 176 159 127 134 117 142.6 96 67.32%

Defense
1/10/2022 Migraines Amb 15,734 15,715 16,462 17,113 16,327 16270.2 66,640 409.58%
1/10/2022 Neoplasm Hosp 1,452 1,341 1,174 1,211 1,094 1254.4 922 73.50%
1/10/2022 Neoplasm Amb 41,557 39,139 37,751 38,887 36,044 38675.6 103, 606 #VALUE!
1/10/2022 Ovarian Cancer Hosp 11 5 11 3 6 7.2 2 27.78%
1/10/2022 Ovarian Cancer Amb 121 88 73 82 69 86.6 181 209.01%

Medical
1/10/2022 PE hosp 164 168 160 171 170 166.6 169 101.44%
1/10/2022 PE Amb 677 701 669 716 968 746.2 3,164 424.02%
1/10/2022 Pituitary Brain tumor hosp 0 0 0 1 0 0.2 0 0.00%
1/10/2022 Pituitary Brain tumor amb 8 8 7 7 7 7.4 14 189.19%
1/10/2022 Pregnancy Amb 64,198 65,751 66,026 70,590 71,111 67535.2 173,741 257.26%
1/10/2022 M62.82 Rhabdomyolysis Hosp 216 209 227 222 198 214.4 440 205.22%

data
1/10/2022 M62.82 Rhabdomyolysis Amb 706 696 740 755 669 713.2 5,162 723.78%
1/10/2022 SAH Hosp 27 13 16 19 19 18.8 17 90.43%
1/10/2022 SAH Amb 219 139 134 170 196 171.6 616 358.97%
1/10/2022 seizures hosp 27 20 21 32 20 24 21 87.50%
1/10/2022 seizures Amb 196 148 130 150 123 149.4 489 327.31%
1/10/2022 suicide 359 496 530 570 550 501 1798 358.88%
1/10/2022 tachycardia hosp 49 72 59 65 53 59.6 39 65.44%
1/10/2022 tachycardia amb 845 814 893 903 849 860.8 2,595 301.46%
1/10/2022 TB Hosp 5 11 7 15 5 8.6 3 34.88%
Raw data from the Defense 1/10/2022 TBAmb
1/10/2022 testicular cancer hosp
1,115
49
694
37
488
39
449
43
238
19
596.8
37.4
467
27
78.25%
72.19%

Medical Epidemiology 1/10/2022 testicular cancer Amb

1/10/2022 Thyroid dysfunction hosp
1,156
125
1,008
108
866
120
880
121
889
103
959.8
115.4
3537
84
368.51%
72.79%
1/10/2022 Thyroid dysfunction amb 8,074 7,696 7,357 7,289 6,891 7461.4 22,620 303.16%
Database, accessible only by 1/10/2022 TIA Hosp
1/10/2022 TIA Amb
41
509
43
453
34
491
29
485
26
467
34.6
481
25
795
72.25%
165.28%

military medical providers. 1/10/2022 Tinnitis Hosp

1/10/2022 Tinnitis Amb 3,112 3,132 3,302 3,759 3,985 3458 21,771 629.58%
1/10/2022 vein dz hosp 186 179 145 176 126 162.4 113 69.58%
1/10/2022 vein dz amb 10,027 9,082 8,575 9,321 8,106 9022.2 16,286 180.51%
1/10/2022 G46 Vascular Syndromes of brain in cerebrovascular diseases Hosp 2 1 2 1 1 1.4 0 0.00%

Shows increases in all 1/10/2022 G46 Vascular Syndromes of brain in cerebrovascular diseases Amb
1/19/2022 U07.1 COVID-19
81
0
62
0
69
0
59
0
64
1,911
67
382.2
176
116,037
262.69%
30360.28%

categories of acute and non- T50.B95A Adverse effect of other viral vaccine, initial encounter Total for five years 914 182.8 1281 700.77%
Date Obtained 2016 2017 2018 2019 2020 Jan to Nov 2021
1/19/2022 A00 to Z99 All disease and injuries Hosp 43,786 43,338 42,024 43,493 40,052 54,776
specific disease and injury. 1/19/2022 A00 to Z99 All disease and injuries Amb
1/19/2022 E00 to E89 Endocrine nutritional and metabolic diseases AMB
2,059,630 2,058,379 2,022,663 2,110,383 1,976,724
33,140 31,825 30,814 31,504 30,506
2045555.8
31557.8
21,512,583
134,053
1051.67%
424.79%
1/19/2022 C00 to D49 Neoplasms (ALL CANCERS) 41,557 39,139 37,756 38,889 36,050 38678.2 114,645 296.41%
D50 to D89 Diseases if the blood and blood forming organs and certain disorders 11341.6
1/19/2022 involving the immune mechanism 11,533 11,122 10,851 11,773 11,429 34,486 304.07%
1/19/2022 C15 to C26 Malignant neoplasms of digestive organs 660 654 633 602 704 650.6 4,060 624.04%
1/19/2022 C73 to C75 Malignant neoplasms of thyroid and other endocrine glands 550 394 369 374 372 411.8 1,950 473.53%
1/19/2022 G46 Vascular syndromes of brain in cerebrovascular diseases 117 96 104 90 110 103.4 238 230.17%
1/19/2022 G00 to G99 Diseases of the Nervous System 82,435 81,998 81,382 85,012 80,786 82322.6 863,013 10.48330592
1/19/2022 H00 to H59 Diseases of the eye and adnexa 88,091 87,712 86,417 91,503 79,529 86650.4 280,206 323.38%
1/19/2022 C15 Malignant neoplasm of esophagus 29 36 35 20 26 29.2 261 893.84%
1/19/2022 D69.3 immune thrombocytopenic purpura 189 186 175 164 161 175 564 322.29%
1/19/2022 B50 Plasmodium Falciparum malaria (VALIDATION DATA) 36 17 39 33 11 27.2 45 165.44%
1/19/2022 I21 Acute Myocardial Infarction 579 615 630 608 629 612.2 1,650 269.52%
1/19/2022 G43 Migraine 15,734 15,714 16,462 17,116 16,331 16271.4 73,490 451.65%
1/19/2022 Mild Cognitive 484 430 403 459 421 439.4 1,958 445.61%
1/19/2022 G35 to G37 Demyelinating Diseases of the CNS 785 737 690 677 648 707.4 3,444 486.85%
1/19/2022 G35 Multiple Sclerosis 479 391 367 400 385 404.4 2,750 680.02%
1/19/2022 G47.4 Narcolepsy and cataplexy 995 898 864 830 766 870.6 2,097 240.87%
Back to 1/19/2022 G30 to G32 Other degenerative diseases of the nervous system 560 500 461 536 489 509.2 2,054 403.38%
1/19/2022 C7A Malignant Neuroendocrine tumors 167 135 98 113 117 126 440 349.21%
Timeline 1/19/2022 E28 Ovarian Dysfunction 862 936 908 945 1,022 934.6 4,086 437.19%
1/19/2022 I26 Pulmonary Embolism 678 701 668 716 968 746.2 3,489 467.57%
1/19/2022 G37.7 Acute Transverse myelitis in demyelinating disease of CNS 46 57 48 35 34 44 202 459.09%
1/19/2022 G45 Transient Cerebral Ischemic Attacks and related syndromes 509 453 491 485 467 481 894 185.86%
1/19/2022 I60 Nontraumatic subarachnoid hemorrhage 219 139 134 170 196 171.6 640 372.96%
1/19/2022 E00 to E07 Disorders of thyroid gland 8,078 7,694 7,357 7,289 6,893 7462.2 24,769 331.93%

1. https://www.afhsc.mil/DMED
 Coercion & Vaccination Injuries
Coercion

Coercion
• The Old Guard
• SM Accounts A-D

Vaccine Injury
• SM A
• SM B
• SM C
• SM D

Back to 3rd Infantry Division Order

Timeline Specifying deletion of Soldier
medical records
Ask yourself:
 What underlying policies have been disseminated that gave
Commanders the idea that calling out personal health information
Infantry Officer Basic Course – 9SEP21 (PHI) was acceptable?
Publicly calling out peoples vaccine status.
 What could lead to personnel being force vaccinated when legitimate
medical records are being deleted?
Lloyd Austin has violated multiple federal laws by not divesting his stock interests in multiple companies and
breaking his ethics agreement.
SECDEF
The penalties for these crimes can include up to 5 years in prison as well as $50,000 fine for each incident or Conflict of
forfeiture of compensation which he received or offered for the prohibited conduct, whichever amount is
greater. interest
Lloyd Austin’s significant financial interests in Tenet Healthcare Corporation are a direct conflict of interest with his order for
the total force to be vaccinated as Tenet Healthcare facilities service areas where SMs would get vaccinations on the civilian
market as many have been ordered to do.
Ethics agreement, signed by
Violation includes 18 U.S. Code § 208 - Acts affecting a personal financial interest Adobe Acrobat
Document
Lloyd Austin on 8 JAN 2021

Lloyd Austin has no Form 4s showing promised divestment, which is a public announcement of insider stock transactions in
a company. This is verified by link (4).

Stock Price of Tenet Healthcare since Stock Price of Raytheon since Stock Price of Nucor since swearing
swearing in swearing in in
Back to
1. https://www.law.cornell.edu/uscode/text/18/208
2. https://www.law.cornell.edu/uscode/text/18/216
Total Value: $3,889,579.14 Timeline
3. https://www.investor.gov/introduction-investing/general-resources/news-alerts/alerts-bulletins/investor-bulletins-69
4. https://www.sec.gov/cgi-bin/own-disp?action=getowner&CIK=0001680876
Profits since swearing-in: $1,264,842.61
• These pictures show a correlation between Tenet Healthcare locations, SECDEF
by county, in relation to covid deaths in those counties. Darker shading
denotes higher death counts. Conflict of
• The treatments prescribed by Tenet healthcare facilities led to disproportionate amounts
of death via ventilator use, usage of Remdesivir as the only available care option, and
interest
denial of alternative treatments that data showed to be effective, such as HCQ and
Ivermectin. 2
• Secretary Austin directly benefited from directed treatments that led to these disproportionate deaths.

Ask yourself:
 Why would Tenet Healthcare block the usage of treatments where data clearly showed its
effectiveness, in favor of more expensive and lethal treatments?

Back to
Timeline
 Conclusions
From the information provided, we can determine that these facts exist:

• There is no FDA-approved Comirnaty in stock

• There is no Comirnaty being produced
• DoD has knowingly violated the rights of servicemembers across ALL of the Services
• The mandate for DoD as presented is unlawful
Therefore, we must come to these conclusions:

• The mandate for servicemembers to receive a “fully approved” vaccine is flawed at best and
must be immediately rescinded
• Servicemembers must be allowed to exercise their Constitutional rights to be exempt from
receiving the vaccine based on religious grounds
• Terry Adirim has gone outside of the scope of her authority in issuing the memo directing
healthcare professionals to treat EUA product as if it were fully authorized
• Lloyd Austin has violated the trust of the US military, while being guilty of breaking Federal law,
as well as ethics commitments

On behalf of the American people, and military service members, we demand

immediate investigations into the lack of transparency, and the flagrant
disregard for the rule of law, by this Congressional body. Anything less further
erodes and degrades the foundation of sacred trust that the American people
place upon those who serve in the military.
Back to
Timeline